Tumor mutation load better predicts the prognosis of patients treated with immune checkpoint inhibitors in upper gastrointestinal cancers: A systematic review and meta‐analysis

Documenti analoghi

• Body composition change indices combined with Prognostic Nutritional Index predicts the clinical outcomes of patients with gastric cancer treated with immune checkpoint inhibitor
  di: Guiming Deng, et al.
  Pubblicazione: (2024)
• Efficacy and predictors of immune checkpoint inhibitors in patients with gallbladder cancer
  di: Zhuo Cheng, et al.
  Pubblicazione: (2024)
• Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor‐associated myocarditis: A systematic review and meta‐analysis
  di: Wenhua Song, et al.
  Pubblicazione: (2024)
• The role of sarcopenic obesity for the prediction of prognosis of patients with gastrointestinal cancer
  di: Wenqing Chen, et al.
  Pubblicazione: (2024)
• Impact of immune‐related adverse events on survival outcomes in extensive‐stage small cell lung cancer patients treated with immune checkpoint inhibitors
  di: Tadashi Nishimura, et al.
  Pubblicazione: (2024)